Blood Cancer United Buys Remaining Supplies of Discontinued Drug

The nonprofit Blood Cancer United is acquiring the last remaining supplies of a discontinued cancer drug, Luvelta. This move aims to ensure patients have access to essential medication despite the drug’s discontinuation.